MMP14 and cervical carcinoma: Moreover, MT1-MMP was used as a potential targeting biomarker for tumor diagnosis and prognosis, including lung cancer, renal cancer, cervical cancer, glioblastomas, prostate cancer and breast cancer [18,22,23,24,25].